-transparent.png){kind=logo}
Isoprodiane (a combination of isoniazid, prothionamide and dapsone) was given to 22 persons with open cavitating pulmonary tuberculosis. None of them had been treated before. Microscopic and cultural sputum conversion occurred within an average of 5 and 11 weeks respectively. Treatment was discontinued in five patients: as a safety measure, despite sputum conversion, on account of the extent of the process and the general condition of the patient (one case); because of side-effects (two cases, one of whom was hypersensitive to isoniazid); because the patients failed to continue with the treatment (two cases). The early results were very promising; the long-term results cannot yet be assessed. The therapy did not materially affect the haemoglobin levels.
C M Quinteros, and
E Chehín, and
E Wayar, and
M Ratner, and
G Amadio
January 1979,
Zhonghua jie he he hu xi xi ji bing za zhi = Chinese journal of tuberculosis and respiratory diseases,
C M Quinteros, and
E Chehín, and
E Wayar, and
M Ratner, and
G Amadio
December 1976,
Anales espanoles de pediatria,
C M Quinteros, and
E Chehín, and
E Wayar, and
M Ratner, and
G Amadio
January 1980,
Praxis und Klinik der Pneumologie,
C M Quinteros, and
E Chehín, and
E Wayar, and
M Ratner, and
G Amadio
March 1976,
Praxis der Pneumologie,
C M Quinteros, and
E Chehín, and
E Wayar, and
M Ratner, and
G Amadio
January 1961,
Revista de la Asociacion Medica Argentina,
C M Quinteros, and
E Chehín, and
E Wayar, and
M Ratner, and
G Amadio
September 1963,
The American review of respiratory disease,
C M Quinteros, and
E Chehín, and
E Wayar, and
M Ratner, and
G Amadio
August 1963,
Der Tuberkulosearzt,
C M Quinteros, and
E Chehín, and
E Wayar, and
M Ratner, and
G Amadio
March 1978,
[Zasshi] [Journal]. Nihon Kyobu Geka Gakkai,
C M Quinteros, and
E Chehín, and
E Wayar, and
M Ratner, and
G Amadio
September 1980,
Nihon Kyobu Shikkan Gakkai zasshi,
C M Quinteros, and
E Chehín, and
E Wayar, and
M Ratner, and
G Amadio
January 1971,
Respiration; international review of thoracic diseases,
